Cantor Fitzgerald Cuts Nyxoah (NASDAQ:NYXH) Price Target to $17.00

Nyxoah (NASDAQ:NYXH) had its price target cut by Cantor Fitzgerald from $18.00 to $17.00 in a report published on Wednesday, Benzinga reports. They currently have an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Nyxoah’s FY2024 earnings at ($1.56) EPS.

NYXH has been the topic of a number of other research reports. Stifel Nicolaus reissued a buy rating and set a $27.00 price objective on shares of Nyxoah in a report on Wednesday. HC Wainwright reaffirmed a buy rating and set a $22.00 price objective (up previously from $18.00) on shares of Nyxoah in a report on Wednesday, March 20th. Oppenheimer lifted their target price on Nyxoah from $17.00 to $20.00 and gave the stock an outperform rating in a research report on Thursday, March 14th. Finally, Piper Sandler upped their target price on Nyxoah from $15.00 to $20.00 and gave the company an overweight rating in a research report on Wednesday, March 6th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of Moderate Buy and a consensus target price of $20.20.

Nyxoah Price Performance

Nyxoah stock opened at $10.10 on Wednesday. The company has a fifty day simple moving average of $11.96 and a 200-day simple moving average of $9.07. The company has a quick ratio of 4.50, a current ratio of 3.94 and a debt-to-equity ratio of 0.13. Nyxoah has a 12-month low of $4.00 and a 12-month high of $20.00.

Nyxoah (NASDAQ:NYXH) last released its quarterly earnings data on Tuesday, March 5th. The company reported ($0.41) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.41). Nyxoah had a negative return on equity of 42.14% and a negative net margin of 843.48%. The business had revenue of $1.96 million during the quarter, compared to analysts’ expectations of $2.01 million. Research analysts expect that Nyxoah will post -1.71 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nyxoah stock. Iron Triangle Partners LP bought a new position in shares of Nyxoah S.A. (NASDAQ:NYXH) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 253,025 shares of the company’s stock, valued at approximately $3,413,000. Nyxoah accounts for about 0.3% of Iron Triangle Partners LP’s investment portfolio, making the stock its 28th largest position.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.